AI-generated summary
The authors retrospectively compared three ways of injecting 5-aminolevulinic acid before red light photodynamic therapy in patients with non-melanoma skin cancer: needle-free, plum-blossom needle and conventional needle. They report a higher treatment response in the needle-free group than in the other two groups, with scarring, redness and poorer cosmetic appearance reported with the needle methods. As a retrospective study, the findings are observational and may be affected by differences between cohorts.
- Who or what was studied
- Patients with non-melanoma skin cancer treated with intralesional 5-aminolevulinic acid followed by red light irradiation, divided into three injection cohorts (conventional needle n = 158, plum-blossom needle n = 118, needle-free n = 105)
- Limits stated in the abstract
- The study is retrospective, so it is observational (evidence level III) and cannot establish causation.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on doi.org.
Record from PubMed, a service of the National Library of Medicine.
How to read a single study: what to check before relying on this kind of research.
Terms in this paper: Photodynamic therapy, Red light therapy. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.